anmelden
FTSE All-Share
5.543,09
PKT
+1,85
PKT
+0,03
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 18.02.20 | Unilever buy | Goldman Sachs Group Inc. | |
| 18.02.20 | Unilever buy | Goldman Sachs Group Inc. | |
| 18.02.20 | Vodafone Group buy | UBS AG | |
| 18.02.20 | HSBC Neutral | UBS AG | |
| 18.02.20 | AstraZeneca buy | Kepler Cheuvreux | |
| 18.02.20 | HSBC Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.02.20 | HSBC Underweight | JP Morgan Chase & Co. | |
| 18.02.20 | HSBC buy | Jefferies & Company Inc. | |
| 18.02.20 | AstraZeneca Sell | UBS AG | |
| 18.02.20 | Barclays buy | UBS AG | |
| 18.02.20 | AstraZeneca buy | Deutsche Bank AG | |
| 18.02.20 | London Stock Exchange (LSE) Hold | Deutsche Bank AG | |
| 18.02.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 18.02.20 | Prudential Neutral | JP Morgan Chase & Co. | |
| 18.02.20 | Barclays buy | Deutsche Bank AG | |
| 18.02.20 | HSBC Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.02.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 18.02.20 | AstraZeneca overweight | Barclays Capital | |
| 18.02.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 18.02.20 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 18.02.20 | Barclays buy | Jefferies & Company Inc. | |
| 18.02.20 | BP Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.02.20 | Barclays Sector Perform | RBC Capital Markets | |
| 18.02.20 | BP Outperform | RBC Capital Markets | |
| 18.02.20 | BP overweight | JP Morgan Chase & Co. | |
| 13.02.20 | BP Outperform | Bernstein Research | |
| 13.02.20 | Barclays buy | UBS AG | |
| 13.02.20 | Barclays Neutral | Goldman Sachs Group Inc. | |
| 13.02.20 | BP buy | Jefferies & Company Inc. | |
| 13.02.20 | Barclays overweight | JP Morgan Chase & Co. | |
| 13.02.20 | BP overweight | Barclays Capital | |
| 12.02.20 | BP Outperform | RBC Capital Markets | |
| 12.02.20 | Unilever Outperform | Credit Suisse Group | |
| 12.02.20 | Unilever Outperform | Credit Suisse Group | |
| 12.02.20 | Vodafone Group buy | HSBC | |
| 12.02.20 | Shell (ex Royal Dutch Shell) buy | HSBC | |
| 12.02.20 | BP buy | HSBC | |
| 12.02.20 | Shell (ex Royal Dutch Shell) buy | HSBC | |
| 12.02.20 | GSK buy | HSBC | |
| 12.02.20 | Vodafone Group buy | UBS AG |